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E-mail address: anamart@bbm1.ucm.es (A.M. MarIn this study, we investigated the role of protein kinase C (PKC) and mitochondrial permeability
transition pore (mPTP) on the effect of ceramide in an in vitro model of ischemia in SH-SY5Y
neuroblastoma cells. In ischemic cell viability studies, a dual effect of ceramide was observed,
depending on ceramide concentration. PKC isoforms are involved in the protective effect of low
concentrations of ceramide. During ischemia, ceramide treatment leads to an increase in the forma-
tion of reactive oxygen species (ROS), which induces a controlled opening of mPTP. This fact pre-
vents mitochondrial Ca2+ overload, which is clearly protective.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction species (ROS), ATP depletion and affects the activities of variousExtensive research has clearly established that sphingolipids,
including ceramide, sphingosine and the phosphorylated forms,
control vital biological functions [1]. Ceramide is generated by
transient hydrolysis of sphingomyelin, by the action of sphingomy-
elinase, in response to a large number of agonists and stress signal
messenger in multiple pathways and act a trigger for apoptosis in
many different cell systems as well as an inhibitor of cell growth
[2]. Several lines of evidence suggest a role of sphingolipid signal-
ling cascade in the mechanism of tissue ischemia/reperfusion in-
jury. Thus, changes in ceramide metabolism have been associated
with tissue damage during rat brain ischemia [3] and rat heart
ischemia [4]. Although ceramide is known by its role in the produc-
tion of apoptosis, it has also been involved in cytoprotection pro-
cesses like preconditioning [5,6].
Ischemia brain damage is an important cause of death and dis-
ability in the world. Delayed neuronal death includes apoptotic
and necrotic processes. During the last years it has been estab-
lished that ischemic preconditioning, can attenuate the necrotic
and apoptotic cell death produced by ischemia [7].
Ceramide has been reported to have numerous effects on
mitochondria, including enhanced generation of reactive oxygenchemical Societies. Published by E
oxygen species; OGD, oxygen
ty transition pore
tínez).components of the mitochondrial electron transport chain [5].
Mitochondria have received attention as the target of protection
against ischemia/reperfusion injury. One potential target is the
mitochondrial permeability transition pore (mPTP). This pore is a
multiprotein complex formed across the two mitochondrial mem-
branes [8]. The mPTP opening in ischemia/recovery may act as a
trigger for apoptosis. In this case, closing of mPTP could avoid
the cellular death. Nevertheless, a controlled and reversible open-
ing of the mPTP can be related to protection [8,9].
It is noteworthy that during ischemia, some protein kinase C
(PKC) isoforms are activated by translocation to different cellular
compartments. PKC e is expressed in neural tissue, and it has been
involved in protective roles against stroke and neural ischemia
[10]. Besides, PKC e has been identiﬁed as a component of the mi-
toKATP signalling cascade [11]. PKC e is suspected to stabilize mito-
chondria activating mitoKATP and modifying mPTP opening [12].
The main objective of the present study was to determine the
involvement of mitochondria in the neuroprotective role of C2-cer-
amide against ischemic-induced cell death.
2. Materials and methods
2.1. Materials
C2-ceramide was purchased from Sigma. The PKC inhibitor bis-
indolylmaleimide (BSM), PKC e translocation inhibitor peptide
(V1–2) and PKC f pseudosubstrate inhibitor myristoylated (PS)lsevier B.V. All rights reserved.
Fig. 1. Effect of exogenous C2-ceramide on cell death subjected to OGD/recovery.
(A) Viability was tested by MTT assay of control cells and of cells submitted to 3 h
OGD and 16 h of recovery (I/R) with or without C2-ceramide (from 1 to 50 lM). (B)
Flow cytometry with annexin V and propidium iodure of control cells and cells
submitted to 3 h OGD and 16 h of recovery (I/R) with or without 10 lM C2-
ceramide. Early apoptotic cells were positive to annexin V but not to propidium
iodure and necrotic or late apoptotic cells were positive to propidium iodure. BSM
(10 nM) or V1–2 (5 lM) or PS (50 nM) was added 10 min before C2- ceramide.
Values are mean ± S.D. of at least three independent experiments. *Statistically
signiﬁcant difference from the corresponding control value (P < 0.05).
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calcein-AM and dihydrorhodamin 123 (DHR 123) were from
Anaspec Inc. Polyclonal antibodies anti-PKC e and anti-PKC f were
purchased from Santa Cruz Inc. Annexin V-FITC/PI kit was from
Biosource.
2.2. Cell culture
SH-SY5Y human neuroblastoma cells were routinely cultured in
Dulbecco’s Modiﬁed Eagle Medium (Sigma) supplemented with
10% foetal bovine serum, 1% penicillin–streptomycin and 1% gluta-
mine in a humidiﬁed incubator in 95% air–5% CO2 at 37 C.
2.3. Determination of cell viability and cell death
Cell viability was measured by MTT as previously described
[13]. In order to measure the percentage of early apoptotic cells
(intact cell membrane, afﬁnity for annexin V-FITC and devoid of
PI staining) and necrotic or late apoptotic cells (the cell membrane
looses its integrity, the cells becomes PI staining) were analyzed by
ﬂow cytometry using an annexin V-FITC/PI kit (Biosource) follow-
ing the manufacturer’s instructions.
2.4. Oxygen glucose deprivation (OGD) model of ischemia
For the experiments we used an in vitro model of ischemia as
described previously [14]. Brieﬂy, the culture medium was re-
placed with a glucose-free buffer (154 mM NaCl, 5.6 mM KCl,
5.0 mM HEPES, 3.6 mM NaHCO3, 2.3 mM CaCl2; pH 7.4), and bub-
bled with 95% N2 and 5% CO2 for at least 2 h before use. Cells were
then placed under hypoxia condition in a hypoxia humidiﬁed
incubator Thermo Electron Corporation (Model 3141), under
atmosphere of 1% O2–5% CO2 at 37 C for 3 h. After this time, for
recovery, the buffer was changed by standard medium and
cells were placed in a humidiﬁed aerobic incubator at 37 C for
16 h.
2.5. Measurement of mPTP opening
To evaluate mPTP opening we used calcein staining procedures
as described [15]. To quenching cytosolic and nuclear calcein 1 mM
CoCl2 was added during calcein loading. After 15 min of incubation
at 37 C C2-ceramide was added just before OGD. Cells were then
placed in a thermostatized sealed chamber on a Leica confocal
microscope in the OGD buffer described above without glucose
as described previously [14]. Calcein AM loaded cells were then
imaged on a Leica confocal microscope. Excitation/emission wave-
length were 488/525 ± 25 nm. Confocal images were acquired and
stored at different time intervals. The data were analyzed using the
data acquisition software LCS Lite Software.
2.6. Measurement of mitochondrial calcium
In order to measure mitochondrial calcium, cells were loaded at
37 C with 2.2 mM rhod-2 AM. Cells were treated with thapsigar-
gin for 20 min before C2-ceramide addition to avoid interferences
by endoplasmic reticulum calcium. For cell analysis, the cultures
were placed in a thermostatized sealed chamber on a Leica confo-
cal microscope as described above.
2.7. Measurement of ROS production
ROS production was measured as described [16]. DHR 123 was
used as a marker for intracellular ROS. Cultures were placed in a
Leica confocal microscope as described above.2.8. Determination of PKCs translocation
PKC isoforms were analyzed in cytosolic and mitochondrial
fractions by Western blotting as previously described [17]. Isola-
tion of mitochondrial fraction was carried out as described [18].
2.9. Statistical analysis
Data are presented as mean ± S.D. Statistical comparisons were
made using Student’s t-test. The p value for signiﬁcance was set at
0.05.
3. Results and discussion
In the present study, we analyzed the action of C2-ceramide on
cell viability, by using an in vitro model of ischemia, maintaining
SH-SY5Y human neuroblastoma cells under OGD. After 3 h of
OGD and 16 h of recovery the cell viability was assessed. Ischemic
treatment produced a decrease in viability around 33% compared
with control. When C2-ceramide was added simultaneously with
the OGD, the effect on the viability proved to be dual depending
on the sphingolipid concentration. Thus, low concentrations of
C2-ceramide protect cell death produced by ischemia/recovery,
reaching the maximum protection when 10 lM C2-ceramide was
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death (Fig 1A). This is in line with recent evidences indicating that
ceramide contributes to reduced or promoted cell viability in pri-
mary osteoblast cultures [19]. During the ischemia cells may die
for apoptosis and/or necrosis. To distinguish these two types of
death, ﬂow cytometry assays were done by using cells control
and cells undergone treatment of OGD/recovery as described
above. The results obtained indicated that after the treatment, cell
death occurred mostly by necrosis and to a lesser extent by apop-
tosis (20 ± 1.3% for necrosis or late apoptosis and 8 ± 1.5% of early
apoptosis). In addition, our results show that 10 lM C2-ceramide
protected from both types of cell death (Fig. 1B). Therefore, our re-
sults indicate that ceramide protected both apoptosis/necrosis cell
death types in SH-SY5Y cells during OGD/recovery. Although cera-
mide usually inhibits proliferation and promotes apoptosis [2], in
our hands, concentration 10 lM ceramide used in this study, did
not provoked any signiﬁcant changes in conditions of normoxia.
We have recently demonstrated that sphingosine-1-phosphate
has a protective effect mediated by PKC e activation [14]. In the
present study, we used different speciﬁc PKC inhibitors, PKC e
V1–2 peptide, which is an inhibitor of the translocation of PKC e
and PS cell-permeable pseudosubstrate (PS), as inhibitor of PKC f.
As shown in Fig 1B, the protective action of 10 lM C2-ceramide
on ischemia-induced cell necrosis was mediated by PKC e, while
PKC f mediated the ceramide effect on both necrotic and apoptotic
ischemic cell death. These ﬁndings demonstrate that, during OGD/
recovery, ceramide protected from the necrosis for a mechanism
involving PKC e and PKC f, whereas the protection of cell death
by apoptosis seems to be mediated only by PKC f. The involvement
of PKC family, especially PKC e isoform, in the mechanism of action
of different protector agents of the OGD/recovery has been de-
scribed previously [11,12]. However, this is the ﬁrst time that
PKC f is related to the protection against ischemia. In this sense,
we must point out that ceramide provoked the cellular survival
in absence of growth factors by a mechanism mediated PKC f as
previously described [20].
In recent years, mitochondria have been recognized as regula-
tors of cell death via both necrosis and apoptosis [21] and it is well
known the involvement of mitochondria in death induced by
ischemia in different experimental models [22]. We also analyzed
the redistribution of both PKC e and PKC f after 10 lMC2-ceramide
treatment. As can be seen in Fig. 2, ceramide caused a translocation
of both PKC isoforms from cytosol to mitochondria This effect was
evident after 1 h C2-ceramide treatment, and it was maintained for
at least 3 h. Our results indicated that both isoforms could be re-
lated to the sphingolipid protection by modulating the different
events that occur in mitochondria during ischemia. In this regard,
an increase of PKC e in mitochondria has been described as a
mechanism of defense against the hypoxia/ischemia insult [23].
Therefore, ceramide seems to act, at least in part, through this
mechanism.Fig. 2. PKC e and PKC f translocation from cytosol to mitochondria by C2-ceramide
action. SH-SY5Y cells were treated with 10 lM C2-ceramide, and mitochondrial and
cytosolic fractions were analyzed by Western blotting using speciﬁc antibodies. The
immunoblots are representative of one of three experiments with similar results.The ROS (e.g., superoxide, hydrogen peroxide and hydroxyl rad-
icals) are well known factors related to ischemia/reperfusion injury
[24]. In this sense, we carried out experiments to study the C2-cer-
amide action on ROS production during the ischemia/recovery, and
the involvement of different isoforms of PKC on this event. The
experiments were done submitting the cells to 60 min of ischemia
and 10 min of recovery. For recovery, glucose was added carefully
to cell culture and the normal level of oxygen was restored. The re-
sults obtained indicated that after treatment, a signiﬁcant increase
of ROS production was observed (Fig. 3). This increase was more
pronounced during the recovery. When C2-ceramide was added
during the ischemia, the production of ROS was increased, how-
ever, during recovery, ROS production diminished respect to the
production during ischemia. The treatment with PKC e and PKC f
inhibitors prevented the C2-ceramide effect. Treatment with V1–
2 prevented the effect of ischemia. Taking into account that one
of the main factors involved in the phenomena of death/protection
during ischemia is the opening/closing of the mPTP, we also tested
the ability of C2-ceramide to affect the mPTP during OGD/recovery.
Results indicated that when C2-ceramide was added during ische-
mia, a decrease in ﬂuorescence was observed, whereas the addition
of cyclosporin, an inhibitor of mPTP, prevented this C2-ceramide
effect (Fig. 4A). The ﬂuorescence decrease (due to the mitochon-
drial exit of calcein) is not produced in presence of PKC e inhibitor
(V1–2) neither PKC f inhibitor (PS) (Fig. 4B). In order to analyze the
implication of the ROS produced for ceramide in the opening of the
mPTP, the cultures submitted to OGD and ceramide were treated
with rotenone, an inhibitor of electron transport. The results indi-
cated that in the presence of rotenone, the C2-ceramide-evoked
mPTP opening was not produced (Fig 4B).
Mitochondrial Ca2+ overload has been suggested as a marker for
injury in ischemia [25]. In this study, changes in Ca2+ levels were
measured with confocal microscopy using rhod-2 AM as a probe.
Our results indicate that the treatment with C2-ceramide in
ischemia conditions provoked the empty of the mitochondrial
Ca2+. This effect was prevented by 1 lM cyclosporin (Fig. 5).
In normal conditions, the mPTP avoid an excessive load of cal-
cium in the mitochondria, by reversible and transitory openings.
Nevertheless, an irreversible opening of the mPTP leads to a signif-
icant fall in ATP, rupture of the mitochondrial outer membrane and
cell death by necrosis and not by apoptosis, since apoptosis is an
ATP-dependent process. However, reversible opening of mPTP will
lead to death by apoptosis or recovery of the cell [9].Fig. 3. Effect of C2-ceramide on ROS generation. Cells were loaded with DHR 123
and were submitted to 1 h of OGD (ischemia) and 20 min of recovery in the
presence or absence of 10 lM C2-ceramide. V1–2 (5 lM) or PS (50 nM) were added
10 min before C2-ceramide treatment. Images were acquired every 5 min. Data are
presented as the percentage of ROS about control and is the result of at least 60 cells
normalized with respect to the initial point for each treatment.
Fig. 4. Action C2-ceramide and OGD/recovery on the mPTP opening. Cells were
loaded with calcein-AM and CoCl2 and were subjected to 1 h of OGD (ischemia), in
the presence or absence of 10 lM C2-ceramide. (A) 1 lM cyclosporin (CsA) was
added 10 min before C2-ceramide treatment. (B) 50 lM V1–2, 50 nM PS or 100 lM
rotenone were added 10 min before C2-ceramide treatment. Images were acquired
every 5 min. Data are presented as relative ﬂuorescence of at least 60 cells
normalized with respect to initial point for each treatment.
Fig. 5. Action of C2-ceramide on mitochondrial calcium during OGD/recovery. Cells
were pretreated with 2 lM thapsigargin, loaded with 2.2 mM rhod-2 AM and were
subjected to 1 h of OGD (ischemia), in the presence or absence of 10 lM C2-
ceramide and 1 lM cyclosporin (CsA) when indicated. Images were acquired every
15 s. Data are presented as relative ﬂuorescence of at least 60 cells normalized with
respect to initial point for each treatment.
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during ischemia, leads to an increase in the formation of ROS,
which induces a controlled opening of mPTP during ischemic pro-
cess. This opening of mPTP during ischemia is clearly dependent on
the formation of ROS by ceramide. This fact has been previously
suggested to be a protective mechanism by some authors [5]. This
controlled opening of mPTP during ischemia prevents mitochon-
drial calcium overload, which is clearly protective. The lowest con-
centration of calcium in the mitochondria and the lowest level of
oxidative stress during recovery, possibly cause a lower opening
of mPTP during recovery. In this way, the cells are retrieved and
prevent cell death during recovery. Both PKC e and PKC f isoforms
are involved in the formation of ROS by C2-ceramide and the open-
ing of the mPTP induced by the sphingolipid.
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